Four years ago, when AMiCI was established, there was clear evidence that antimicrobial resistance (AMR) had emerged as a global health risk. While effective and prudent stewardship of antimicrobial products were being promoted as necessary for management and potential mitigation of this risk, there was increasing recognition of the possibilities that antimicrobial coatings (AMCs) presented. AMCs and some associated technologies were not necessarily new. For
Due to the coronavirus pandemic, the healthcare sector is facing a totally new challenge. Satakunta University of Applied Sciences (SAMK) from Finland leads a European-wide network, which develops touch surfaces for infection prevention. AMiCI ePlatform network will speed up the market entry of new antimicrobial surfaces.
Final AMiCI Conference placed in Kraków on February 18-20 is already history. The main target of the conference was to summarize the AMiCI action with the view to formulate the official statement of antimicrobial coatings addressed to EU. Final days that took place in Jagiellonian University, Faculty of Chemistry brought the expected results. The program and selected presentations are presented in order of appearance. AMiCI
Final conference of COST Action AMiCi will take place in February in Krakow. The three days event will encompass the Core Group and Management Committee meetings and two-day conference. The conference will aim to summarize the AMiCI action with the view to formulate the official statement of antimicrobial coatings addressed to EU, as well as discuss achievements of working groups and ways forward. 18th February
We invite you to join the webinar that will be hosted by The EU Health Policy Platform. Webinar starts on Monday 13 January 2020, 14h30-16h CET Brussels time. Agenda of the webinar 14.30–14.35 Introduction and welcome Ann Marie Borg, European Public Health Alliance (EPHA) 14.35–15.10 Presentation of the Roadmap for Action on AMRby members of the AMR Stakeholder Network European Public Health Alliance (EPHA) Federation
CA15114 COST AMiCI welcomes, especially early career investigators to apply for “Training school on assessment of effectivity of antimicrobial coatings (AMCs)”, Wednesday to Friday 29th to 31st of January 2020 University of Latvia, Jelgavas str. 1, Riga, Latvia. The training school is led by COST AMiCI WG4 leader Dr. Martina Modic and WG2 vice leader Dr. Patrick Cosemans. Travel costs are reimbursed according to COST
A variety of bacteria such as Staphylococcus aureus and Staphylococcus epidermidis can survive in host cell, even in phagocystes (e.g. macrophages) after phagocytosis, causing intracellular infections. Treatment of this intracellular infections often fails due to the low intracellular efficacy of most conventional antimicrobials such as antibiotics. Thus, novel techniques that can improve intracellular efficacy of antibiotics are highly needed. Poster presented by Xiaolin Zhang during
THE POLY-PREVENTT project poster presented during the AMiCI Workshop for Early Career Investigators (ECIs) and Short Term Scientific Missions (STSM). Riga, Latvia, 7th of March 2019 by Suzana Lopez.
In this work, two antifouling polymer brushes were tested at different shear stress conditions to evaluate their performance in reducing the initial adhesion of Escherichia coli. Assays were performed using a parallel plate flow chamber and a shear stress range between 0.005 and 0.056 Pa, previously determined by numerical simulation. These shear stress valuesare found in different locations in the human body where biomedical devices
Papadopoulos Panagiotis 2019 Chitosan is a natural, nontoxic, biodegradable biopolymer which derives by the deacetylation of chitin, a main component of the shells of crustaceans such shrimp, crab and crawfish. Chitosan as well as it’s oligomers, receive considerable attention due to their antimicrobial, antitumor and hypocholesterolemic abilities. Chitosan based edible coating and films, incorporated or not with other antimicrobial agents (essential oils, lauric alginate, ester,